Federated Hermes’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,539
| Closed | -$30K | – | 2334 |
|
|
2018
Q1 | $30K | Sell |
1,539
-13,161
| -90% | -$258K | ﹤0.01% | 1710 |
|
|
2017
Q4 | $244K | Sell |
14,700
-221,526
| -94% | -$4.06M | ﹤0.01% | 1488 |
|
|
2017
Q3 | $4.8M | Buy |
236,226
+148,813
| +170% | +$2.84M | 0.01% | 593 |
|
|
2017
Q2 | $1.41M | Sell |
87,413
-496,105
| -85% | -$7.33M | ﹤0.01% | 1087 |
|
|
2017
Q1 | $7.38M | Buy |
583,518
+296,563
| +103% | +$3.58M | 0.02% | 481 |
|
|
2016
Q4 | $3.8M | Buy |
286,955
+270,655
| +1,660% | +$4.63M | 0.01% | 637 |
|
|
2016
Q3 | $387K | Buy |
+16,300
| New | +$438K | ﹤0.01% | 1350 |
|
|
2015
Q4 | – | Sell |
-182
| Closed | -$6K | – | 2200 |
|
|
2015
Q3 | $6K | Sell |
182
-4
| -2% | -$180 | ﹤0.01% | 1776 |
|
|
2015
Q2 | $9K | Sell |
186
-318,857
| -100% | -$15.1M | ﹤0.01% | 1737 |
|
|
2015
Q1 | $15M | Sell |
319,043
-31,258
| -9% | -$1.24M | 0.05% | 369 |
|
|
2014
Q4 | $11.1M | Sell |
350,301
-95,181
| -21% | -$2.79M | 0.03% | 425 |
|
|
2014
Q3 | $10.6M | Buy |
445,482
+222,944
| +100% | +$5.71M | 0.03% | 426 |
|
|
2014
Q2 | $6.67M | Buy |
222,538
+676
| +0.3% | +$18.2K | 0.02% | 569 |
|
|
2014
Q1 | $5.86M | Sell |
221,862
-7,704
| -3% | -$193K | 0.02% | 593 |
|
|
2013
Q4 | $5.77M | Buy |
229,566
+36,684
| +19% | +$818K | 0.02% | 590 |
|
|
2013
Q3 | $3.96M | Sell |
192,882
-3,745
| -2% | -$77.3K | 0.02% | 664 |
|
|
2013
Q2 | $3.92M | Buy |
+196,627
| New | +$3.49M | 0.02% | 650 |
|
Federated Hermes's IPXL Position: Q2 2018 in Review
Federated Hermes sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,539 shares — an estimated $30K sold.
Federated Hermes first reported a position in IPXL in Q2 2013 and held it in 17 quarters. The position peaked at $15M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Federated Hermes reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Federated Hermes sold 1,539 Impax Laboratories, Inc. shares in Q2 2018, an estimated $30K.
- Federated Hermes first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 17 quarters.
- Federated Hermes's Impax Laboratories, Inc. position peaked at $15M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Federated Hermes's 13F filing for Q2 2018, filed 10 Aug 2018.